Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epirubicin and Celecoxib in Hepatocellular Carcinoma
NCT00057980Phase 2Completed
- Sponsor
- Northwestern University
- Start
- Oct 2002
- Primary completion
- Feb 2007
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of epirubicin, celecoxib in hepatocellular carcinoma (HCC), sponsored by Northwestern University. Started Oct 2002; status: completed.
02
Drugs
epirubicincelecoxib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00057980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00057980.